Published: 01/30/2023 14:41 GMT Evoke Pharma Inc (EVOK) - Evoke Announces Teva Ends Pursuit of Paragraph Iv Anda Against Gimoti.
Evoke Pharma - in Addition, No Future Anda Filer Will Be Eligible to Receive 180-day Generic Exclusivity for an Anda That References Gimoti.
